Literature DB >> 6308641

Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor.

H Marquardt, M W Hunkapiller, L E Hood, D R Twardzik, J E De Larco, J R Stephenson, G J Todaro.   

Abstract

Transforming growth factors (TGFs) were purified from serum-free medium conditioned by retrovirus-transformed Fisher rat embryo fibroblasts, mouse 3T3 cells, and two human melanoma cell lines. The purification of each TGF was monitored in a radioreceptor assay based on receptor crossreactivity with mouse submaxillary gland epidermal growth factor (mEGF) and was achieved by gel permeation chromatography of the acid-soluble TGF-containing activity, followed by reverse-phase high-pressure liquid chromatography with sequential use of acetonitrile and 1-propanol in the presence of aqueous trifluoroacetic acid. The amino-terminal sequences of rat, mouse, and human TGFs were determined. Extensive sequence homology was found among TGF polypeptides from different species and cell types. Alignment of the amino acid sequences of rat TGF, mEGF, and human urogastrone (hEGF) reveals statistically significant sequence homology. The reported results suggest that TGFs that compete for binding to the cellular EGF receptor and EGF may have evolved from a common progenitor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308641      PMCID: PMC384108          DOI: 10.1073/pnas.80.15.4684

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Abelson murine leukemia virus-infected cell lines defective in transformation.

Authors:  T L Sacks; E J Hershey; J R Stephenson
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

2.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization.

Authors:  C R Savage; S Cohen
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

4.  Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF.

Authors:  A B Roberts; M A Anzano; L C Lamb; J M Smith; C A Frolik; H Marquardt; G J Todaro; M B Sporn
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

5.  Characterization of the binding protein for epidermal growth factor.

Authors:  J M Taylor; W M Mitchell; S Cohen
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

6.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

7.  A protein sequenator.

Authors:  P Edman; G Begg
Journal:  Eur J Biochem       Date:  1967-03

8.  Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors.

Authors:  B Ozanne; R J Fulton; P L Kaplan
Journal:  J Cell Physiol       Date:  1980-10       Impact factor: 6.384

9.  Properties of a sarcoma-growth-factor-like peptide from cells transformed by a temperature-sensitive sarcoma virus.

Authors:  J E De Larco; Y A Preston; G J Todaro
Journal:  J Cell Physiol       Date:  1981-10       Impact factor: 6.384

10.  Human transforming growth factor. Production by a melanoma cell line, purification, and initial characterization.

Authors:  H Marquardt; G J Todaro
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

View more
  83 in total

Review 1.  Application of molecular cytogenetic techniques to the evaluation of renal parenchymal tumors.

Authors:  G Kovacs
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors.

Authors:  A M Sizeland; A W Burgess
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Galactosamine induced hepatitis induces a reduction in hepatocyte epidermal growth factor receptors.

Authors:  D A Vesey; A C Woodman; H J Hodgson
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

4.  Hydrolysis of transforming growth factor-alpha by cell-surface peptidases in vitro.

Authors:  Y Choudry; A J Kenny
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

5.  Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1.

Authors:  K A Thomas; M Rios-Candelore; G Giménez-Gallego; J DiSalvo; C Bennett; J Rodkey; S Fitzpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas.

Authors:  V Samuels; J M Barrett; S Bockman; C G Pantazis; M B Allen
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

7.  Preimplantation embryo development in vitro: cooperative interactions among embryos and role of growth factors.

Authors:  B C Paria; S K Dey
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor.

Authors:  I A McKay; P Malone; C J Marshall; A Hall
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

9.  Transforming growth factor-alpha: characterization of the BamHI, RsaI, and TaqI polymorphic regions.

Authors:  J F Qian; J Feingold; C Stoll; E May
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

10.  Contraception potential of neem oil: effect on pregnancy success in the mouse.

Authors:  S C Juneja; R S Williams; A Farooq; N Chegini
Journal:  J Assist Reprod Genet       Date:  1996-08       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.